A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 1 52-1, 2005, Pages

  Peeters, Robin P ^a   Van Den Beld, Annewieke W ^a   Attalki, Hayat ^a   Van Toor, Hans ^a   De Rijke, Yolanda B ^a   Kuiper, George G J M ^a   Lamberts, Steven W J ^a   Janssen, Joop A M J L ^a   Uitterlinden, Andre G ^a   Visser, Theo J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Association; Iodothyronines; Open reading frame; Population

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

5' UNTRANSLATED REGION; ADULT; AGED; AGING; ARTICLE; BLOOD BANK; BLOOD DONOR; CONTROLLED STUDY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; OPEN READING FRAME; PRIORITY JOURNAL; SKELETAL MUSCLE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TYPE II DEIODINASE GENE;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; ARYL HYDROCARBON HYDROXYLASES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; INCIDENCE; IODIDE PEROXIDASE; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; STATISTICS; THYROID HORMONES;

EID: 21044432096     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00571.2004     Document Type: Article

References (38)

1. Bartha T, Kim SW, Salvatore D, Gereben B, Tu HM, Harney JW, Rudas P, and Larsen PR. Characterization of the 5′-flanking and 5′-untranslated regions of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 141: 229-237, 2000.
2. Bianco AC, Salvatore D, Gereben B, Berry MJ, and Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89, 2002.
3. Buettner C, Harney JW, and Larsen PR. The 3′-untranslated region of human type 2 iodothyionine deiodinase mRNA contains a functional selenocysteine insertion sequence element. J Biol Chem 273: 33374-33378, 1998.
4. Canettieri G, Celi FS, Baccheschi G, Salvatori L, Andreoli M, and Centanni M. Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology 141: 1804-1813, 2000.
5. Celi FS, Canettieri G, Mentuccia D, Proietti-Pannunzi L, Fumarola A, Sibilla R, Predazzi V, Ferraro M, Andreoli M, and Centanni M. Structural organization and chromosomal localization of the human type II deiodinase gene. Eur J Endocrinol 143: 267-271, 2000.
6. Croteau W, Davey JC, Galton VA, and St Germain DL. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98: 405-417, 1996.
7. Donda A, and Lemarchand-Beraud T. Aging alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 124: 1305-1309, 1989.
8. Geffner DL, Azukizawa M, and Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest 55: 224-229, 1975.
9. Gereben B, Kollar A, Harney JW, and Larsen PR. The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression. Mol Endocrinol 16: 1667-1679, 2002.
10. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, and Mori M. Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab 84: 3293-3300, 1999.
11. Kozak M. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc Natl Acad Sci USA 83: 2850-2854, 1986.
12. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148, 1987.
13. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115: 887-903, 1991.
14. Larsen PR, Davies TF, and Hay ID. The thyroid gland. In: Williams Textbook of Endocrinology, (9th ed.), edited by Wilson JD, Foster DW, Kronenberg HM, and Larsen PR. Philadelphia, PA: WB Saunders, 1998, p. 389-515.
15. Leonard JL and Koehrle J. Intracellular pathways of iodothyronine metabolism. In: Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text (8th ed.). Philadelphia, PA: Lippincot Williams & Wilkins, 2000, p. 136-173.
16. LoPresti JS, Eigen A, Kaptein E, Anderson KP, Spencer CA, and Nicoloff JT. Alterations in 3,3′,5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest 84: 1650-1656, 1989.
17. Maeda A, Toyoda N, Yasuzawa-Amano S, Iwasaka T, and Nishikawa M. Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells. Mol Cell Endocrinol 200: 111-117, 2003.
18. McGraw DW, Forbes SL, Kramer LA, and Liggett SB. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 102: 1927-1932, 1998.
19. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR, and Celi FS. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 51: 880-883, 2002.
20. Mizuma H, Murakami M, and Mori M. Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res 88: 313-318, 2001.
21. Olivieri O, Girelli D, Stanzial AM, Rossi L, Bassi A, and Corrocher R. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res 51: 31-41, 1996.
22. Parola AL and Kobilka BK. The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 269: 4497-4505, 1994.
23. Peeters RP, van den Beld AW, van Toor H, Uitterlinden AG, Jansen JAMJL, Lamberts SWJ, and Visser TJ. A polymorphism in type I deiodinases is associated with circulating free IGF-I levels and body composition in humans. J Clin Endocrinol Metab 90: 256-263, 2005.
24. Peeters RP, van Toor H, Klootwijk W, deRijke YB, Kuiper GG, Uitterlinden AG, and Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88: 2880-2888, 2003.
25. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, and Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88: 3202-3211, 2003.
26. Reitman ML, He Y, and Gong DW. Thyroid hormone and other regulators of uncoupling proteins. Int J Obes Relat Metab Disord 23 Suppl 6: S56-S59, 1999.
27. Rifai N, Cole TG, Iannotti E, Law T, Macke M, Miller R, Dowd D, and Wiebe DA. Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay. Clin Chem 44: 1452-1458, 1998.
28. Rifai N, Iannotti E, DeAngelis K, and Law T. Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chem 44: 1242-1250, 1998.
29. Saberi M, Sterling FH, and Utiger RD. Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest 55: 218-223, 1975.
30. Salvatore D, Bartha T, Harney JW, and Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137: 3308-3315, 1996.
31. Salvatore D, Tu H, Harney JW, and Larsen PR. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-968, 1996.
32. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, and Galton VA. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15: 2137-2148, 2001.
33. Silva JE. Thyroid hormone control of thermogenesis and energy balance. Thyroid 5: 481-492, 1995.
34. Silva JE and Larsen PR. Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198: 617-620, 1977.
35. Stephens M, Smith NJ, and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989, 2001.
36. Van den Beld A, Huhtaniemi IT, Pettersson KS, Pols HA, Grobbee DE, de Jong FH, and Lamberts SW. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 84: 1334-1339, 1999.
37. Visser TJ, Docter R, and Hennemann G. Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol 73: 395-396, 1977.
38. Wassen FW, Klootwijk W, Kaptein E, Duncker DJ, Visser TJ, and Kuiper GG. Characteristics and thyroid state-dependent regulation of iodothyronine deiodinases in pigs. Endocrinology 145: 4251-4263, 2004.